| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11029324 | Lung Cancer | 2018 | 30 Pages |
Abstract
LAT was the strongest predictor for PFS and OS in OMD with â¤4 metastases. Survival in the control group identifies OMD as a subset of lung cancer with a generally more favorable prognosis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Nikolaj Frost, Antje Tessmer, Alexander Schmittel, Vincent van Laak, Matthias Raspe, Christoph Ruwwe-Glösenkamp, Matthias Brunn, Carolin Senger, Dirk Böhmer, Sebastian Ochsenreither, Bettina Temmesfeld-Wollbrück, Christian Furth, Bernd Schmidt,